Breast cancer cells have increased nuclear localization of NF-κB and malignant melanoma cells have constitutive IκB kinase activation, resulting in rapid degradation of IκB and increased NF-κB translocation and activity [48–50]. This evidence concerns the gene NFKB1 and breast cancer.